177 related articles for article (PubMed ID: 27586026)
1. Contraception with RISUG
Ansari AS; Badar A; Balasubramanian K; Lohiya NK
Asian J Androl; 2017; 19(4):389-395. PubMed ID: 27586026
[TBL] [Abstract][Full Text] [Related]
2. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
Ansari AS; Hussain M; Khan SR; Lohiya NK
Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
[TBL] [Abstract][Full Text] [Related]
3. Safety evaluation through genotoxicity and apoptotic markers following RISUG
Ansari AS; Badar A; Lohiya NK
Reprod Toxicol; 2018 Oct; 81():84-92. PubMed ID: 30036573
[TBL] [Abstract][Full Text] [Related]
4. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.
Lohiya NK; Suthar R; Khandelwal A; Goyal S; Ansari AS; Manivannan B
Int J Androl; 2010 Feb; 33(1):e198-206. PubMed ID: 19811546
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of genotoxicity in leukocytes and testis following intra-vasal contraception with RISUG and its reversal by DMSO and NaHCO₃ in Wistar albino rats.
Ansari AS; Alam I; Hussain M; Khan SR; Lohiya NK
Reprod Toxicol; 2013 Apr; 36():53-9. PubMed ID: 23246611
[TBL] [Abstract][Full Text] [Related]
6. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
Guha SK
Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
[TBL] [Abstract][Full Text] [Related]
7. Studies on biochemical, oxidative and genotoxicity alterations following vas blockage with reversible inhibition of sperm under guidance and reversal in rats.
Ansari AS; Hussain M; Khan SR; Badar A; Khilwani B; Lohiya NK
Indian J Pharmacol; 2022; 54(1):33-40. PubMed ID: 35343205
[TBL] [Abstract][Full Text] [Related]
8. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.
Guha SK
Asian J Androl; 2007 Mar; 9(2):221-7. PubMed ID: 17334590
[TBL] [Abstract][Full Text] [Related]
9. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.
Sharma RS; Mathur AK; Singh R; Das HC; Singh GJ; Toor DPS; Guha SK
Indian J Med Res; 2019 Jul; 150(1):81-86. PubMed ID: 31571633
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and Mutagenicity Evaluation Following RISUG Contraception Reversal in Rats.
Ansari AS; Hussain M; Khan SR; Badar A; Lohiya NK
Int J Toxicol; 2018 Nov; ():1091581818809473. PubMed ID: 30380967
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation for noninvasive reversal following long-term vas occlusion with styrene maleic anhydride in langur monkeys.
Lohiya NK; Manivannan B; Mishra PK; Sriram S; Bhande SS; Panneerdoss S
Contraception; 2005 Mar; 71(3):214-26. PubMed ID: 15722073
[TBL] [Abstract][Full Text] [Related]
12. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys.
Lohiya NK; Manivannan B; Mishra PK
Int J Androl; 2000 Feb; 23(1):36-42. PubMed ID: 10632760
[TBL] [Abstract][Full Text] [Related]
13. Sperm impairing microbial factor: potential candidate for male contraception.
Chauhan A; Thaper D; Prabha V
Reprod Biol Endocrinol; 2020 Sep; 18(1):96. PubMed ID: 32998760
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical trial of an injectable contraceptive for the male.
Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
[TBL] [Abstract][Full Text] [Related]
15. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
Lohiya NK; Manivannan B; Mishra PK; Pathak N; Balasubramanian SP
Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
[TBL] [Abstract][Full Text] [Related]
16. The use of URYX for reversible vasectomy in a rabbit model.
Naughton CK; Myles J; Thomas AJ
J Androl; 2004; 25(4):545-53. PubMed ID: 15223843
[TBL] [Abstract][Full Text] [Related]
17. Reversible inhibition of sperm under guidance as an intratubular and reversible contraception in female rats: An experimental study.
Salam Ansari A; Sevliya K; Badar A; Lohiya NK
Int J Reprod Biomed; 2021 Jan; 19(1):47-56. PubMed ID: 33554002
[TBL] [Abstract][Full Text] [Related]
18. RISUG
Khilwani B; Badar A; Ansari AS; Lohiya NK
Basic Clin Androl; 2020; 30():2. PubMed ID: 32082579
[TBL] [Abstract][Full Text] [Related]
19. Status of spermatogenesis and sperm parameters in langur monkeys following long-term vas occlusion with styrene maleic anhydride.
Mishra PK; Manivannan B; Pathak N; Sriram S; Bhande SS; Panneerdoss S; Lohiya NK
J Androl; 2003; 24(4):501-9. PubMed ID: 12826690
[TBL] [Abstract][Full Text] [Related]
20. A short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUG.
Chaki SP; Das HC; Misro MM
Contraception; 2003 Jan; 67(1):73-8. PubMed ID: 12521662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
